Latif Nasser

And they showed that the survival difference between the people who got Zaltrap and the people who didn't was 1.4 months or 42 days.

In other words, if you take this drug, you could get 42 more days of life on average, which means you could get three more days, you could get no days, you could get 42, or you could live another three years.

Forty-two.

42 days.

Oh, please.

I could show you some graphs that have been put up at meetings that show survival curves calculated out to two decimal places in terms of months.

So I'm looking at this.

That's like not a tenth of a month.

A hundredth of a month.

A hundredth of a month.

That's a little over seven hours.

What?

Pretty amusing, actually.

Why would you...

It's pseudo-precision.

Pseudo-precision.

Anyways, after the conference, the FDA approves the drug.

And basically, once the FDA approves the drug, public insurance has to take it.

And then the private insurance companies just follow suit, which means you get prescribed the drug and people pay for it.

And what does the drug cost?